Global Opportunities and Trends of Microcarrier Market
The global microcarriers market is expected to reach USD 1.61 billion by 2023 from USD 1.20 billion in 2018, at a CAGR of 6.0%. Growth in this market is driven by the rising demand for cell-based vaccines, technological advancements, and the availability of public and private funding for cell-based research.
Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=139831731
Based...
Cell Culture Market 2018, Trend, Geographical Segmentation, Forecast, Application
The global cell culture market is expected to reach USD 26.28 Billion by 2023 from USD 15.32 Billion in 2018, at a CAGR of 11.4%. This market is experiencing significant growth due to the growing number of regulatory approvals for cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, and the...
Technological Advancements in Disease Diagnostics Driving Microbiology Testing/Clinical Microbiology Market
The clinical microbiology market is projected to register a CAGR of 6.4%, growing from USD 3.63 billion in 2018 to USD 4.95 billion in 2023. Growth in clinical microbiology market can be attributed to factors such as rising incidence of infectious diseases and growing outbreak of epidemics and increased funding and public-private investments.
Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=219135367
The...
Transfer Membrane Market | Projected to Reach USD 187.9 Million |At a CAGR of 1.5% |Global Forecast to 2023
The global transfer membrane market is projected to reach 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5%. Factors such as increasing public and private funding for life science research, high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to drive the growth of this market. However,...
Nuclear Medicine/Radiopharmaceuticals Market is is projected to expand at a healthy CAGR of 5.9% by 2023
The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from an estimated USD 3.95 billion in 2018, at a CAGR of 5.9%. Growth in this market is mainly driven by factors such as the increasing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. Moreover, the use of radiopharmaceuticals in novel neurological applications...
Increasing Incidence of Blood Disorders and Integration of Hematology Analyzers With Flow Cytometry Driving Hematology Analyzers and Reagents Market
The global hematology products market is projected to reach USD 4.98 billion by 2023 from USD 3.31 billion in 2018, at a CAGR of 8.5%. The growth in blood donation and the increasing incidence of blood disorders are the major factors driving the growth of the global hematology analyzers and reagents market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=153222146
In this...
High Prevalence of Infectious Diseases and Various Types of Cancers– A Key Factor Driving The Market for Molecular Diagnostics
The global molecular diagnostics market is projected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at CAGR of 8.4%. Growth in this market is driven by the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular...
Favorable Regulations Driving the Use of Biological Safety Cabinets in the Healthcare Industry
The biological safety cabinets market is projected to reach USD 205.9 million by 2022 from USD 144.3 million in 2017, at a CAGR of 7.4% during the forecast period.
Growth in the biological safety cabinets market is mainly driven by factors such as favorable regulations, increased risk of pandemics and communicable diseases, increasing number of R&D activities in biotechnological and pharmaceutical...
Specimen Validity Testing Market is Primarily Driven by The Growth in Drug Screening Market And Increase in Workplace Drug Testing
The global specimen validity testing market is projected to reach USD 1.49 billion by 2023 from USD 1.10 billion in 2018, at a CAGR of 6.3%. The growth of the specimen validity testing market is primarily driven by the growth in the drug screening market and increase in workplace drug testing.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=147024121
The specimen validity...
Neuroscience Antibodies & Assays Market : Rising Incidence of Neurological Diseases
The global neuroscience antibodies and assays market is expected to reach USD 4.18 billion by 2023 from USD 2.57 billion in 2018, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. On the other hand, quality and cost concerns over the production...